INVESTOR NOTICE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action – Hagens Berman
SAN FRANCISCO, April 15, 2026 /PRNewswire/ — ImmunityBio, Inc. (NASDAQ: IBRX) faces a securities class action lawsuit which seeks to…
